What is the dosing for Amoxicillin-Clavulanate (Amoxyclav)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

  1. Dosage and Administration Amoxicillin and clavulanate potassium may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when amoxicillin and clavulanate potassium is administered at the start of a meal. The usual adult dose is one 500 mg/125 mg amoxicillin and clavulanate potassium tablet every 12 hours or one 250 mg/125 mg amoxicillin and clavulanate potassium tablet every 8 hours For more severe infections and infections of the respiratory tract, the dose should be one 875 mg/125 mg amoxicillin and clavulanate potassium tablet every 12 hours or one 500 mg/125 mg amoxicillin and clavulanate potassium tablet every 8 hours. Based on the amoxicillin component, amoxicillin and clavulanate potassium should be dosed as follows: Neonates and Infants Aged <12 weeks (<3 months): The recommended dose of amoxicillin and clavulanate potassium tablet is 30 mg/kg/day divided every 12 hours, based on the amoxicillin component Patients Aged 12 weeks (3 months) and Older: See dosing regimens provided in Table 1.

The dosing for Amoxicillin-Clavulanate (Amoxyclav) is as follows:

  • Adults:
    • Usual dose: 500 mg/125 mg every 12 hours or 250 mg/125 mg every 8 hours
    • For more severe infections: 875 mg/125 mg every 12 hours or 500 mg/125 mg every 8 hours
  • Pediatric Patients:
    • Neonates and Infants Aged <12 weeks: 30 mg/kg/day divided every 12 hours
    • Patients Aged 12 weeks and Older:
      • Every 12 hours: 45 mg/kg/day for otitis media, sinusitis, lower respiratory tract infections, and more severe infections; 25 mg/kg/day for less severe infections
      • Every 8 hours: 40 mg/kg/day for otitis media, sinusitis, lower respiratory tract infections, and more severe infections; 20 mg/kg/day for less severe infections
      • Patients weighing 40 kg or more should be dosed according to adult recommendations 1

From the Research

Amoxyclav (amoxicillin-clavulanate) is typically dosed based on the amoxicillin component, with standard adult dosing at 875mg/125mg twice daily or 500mg/125mg three times daily for most infections, as supported by the most recent and highest quality study 2. The recommended dose for children is 20-40mg/kg/day of the amoxicillin component divided into two or three doses, depending on infection severity. Key points to consider when prescribing Amoxyclav include:

  • Treatment duration usually ranges from 7-14 days, with 10 days being common for most respiratory and soft tissue infections.
  • The medication should be taken with food to reduce gastrointestinal side effects and improve clavulanate absorption.
  • Dosage adjustments are necessary for patients with renal impairment, with reduced frequency recommended for creatinine clearance below 30ml/min.
  • Amoxyclav works by combining amoxicillin, which disrupts bacterial cell wall synthesis, with clavulanic acid, which inhibits beta-lactamase enzymes that would otherwise inactivate amoxicillin.
  • This combination makes it effective against many beta-lactamase-producing bacteria that would be resistant to amoxicillin alone, including certain strains of Staphylococcus, Haemophilus influenzae, and Escherichia coli, as noted in studies such as 3 and 2. Some specific dosing considerations include:
  • For community-acquired pneumonia, a pharmacokinetically enhanced formulation of oral amoxycillin-clavulanate (2000/125 mg), twice daily, may be used, as shown in 2.
  • For pediatric use, Amoxicillin/clavulanate 90/6.4 mg/kg/day in two divided doses (Augmentin ES-600) is recommended for persistent or recurrent acute otitis media, as mentioned in 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.